Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $561,919 | 75 | 89.6% |
| Travel and Lodging | $27,184 | 74 | 4.3% |
| Grant | $22,500 | 2 | 3.6% |
| Unspecified | $6,953 | 9 | 1.1% |
| Honoraria | $4,500 | 5 | 0.7% |
| Food and Beverage | $3,932 | 73 | 0.6% |
| Education | $126.40 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| W. L. Gore & Associates, Inc. | $470,876 | 132 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $55,518 | 42 | $0 (2024) |
| Shire North American Group Inc | $19,921 | 21 | $0 (2018) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $15,000 | 1 | $0 (2021) |
| Dompe US, Inc. | $13,313 | 11 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $11,054 | 7 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $9,210 | 2 | $0 (2024) |
| GENZYME CORPORATION | $6,448 | 4 | $0 (2017) |
| Alcon Vision LLC | $6,052 | 3 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $3,700 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188,970 | 73 | W. L. Gore & Associates, Inc. ($163,864) |
| 2023 | $16,529 | 10 | Dompe US, Inc. ($9,188) |
| 2022 | $10,337 | 14 | Bausch & Lomb Americas Inc. ($8,950) |
| 2021 | $23,706 | 32 | Bausch & Lomb, a division of Bausch Health US, LLC ($15,000) |
| 2020 | $96,703 | 29 | W. L. Gore & Associates, Inc. ($70,475) |
| 2019 | $49,760 | 29 | W. L. Gore & Associates, Inc. ($33,806) |
| 2018 | $207,658 | 25 | W. L. Gore & Associates, Inc. ($196,444) |
| 2017 | $33,450 | 27 | Regeneron Pharmaceuticals, Inc. ($15,588) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $32,000.00 | General |
| Category: Devices | ||||||
| 12/16/2024 | Alcon Vision LLC | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 12/16/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Travel and Lodging | In-kind items and services | $179.76 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $12,000.00 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Devices | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: Devices | ||||||
| 11/14/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Travel and Lodging | In-kind items and services | $427.97 | General |
| Category: Devices | ||||||
| 11/13/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Travel and Lodging | In-kind items and services | $358.96 | General |
| Category: Devices | ||||||
| 11/08/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $16,000.00 | General |
| Category: Devices | ||||||
| 11/08/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| Category: Devices | ||||||
| 11/08/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $6,400.00 | General |
| Category: Devices | ||||||
| 11/08/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Devices | ||||||
| 11/07/2024 | Alcon Vision LLC | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 11/05/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,075.00 | General |
| 10/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $143.53 | General |
| Category: Ophthalmology | ||||||
| 10/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Travel and Lodging | In-kind items and services | $56.11 | General |
| Category: Ophthalmology | ||||||
| 10/28/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Food and Beverage | In-kind items and services | $55.72 | General |
| Category: Devices | ||||||
| 10/23/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Food and Beverage | In-kind items and services | $96.97 | General |
| Category: Devices | ||||||
| 10/20/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Food and Beverage | In-kind items and services | $78.34 | General |
| Category: Devices | ||||||
| 10/18/2024 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $130.17 | General |
| 10/11/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Travel and Lodging | In-kind items and services | $179.40 | General |
| Category: Devices | ||||||
| 10/11/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Food and Beverage | In-kind items and services | $39.02 | General |
| Category: Devices | ||||||
| 10/10/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Food and Beverage | In-kind items and services | $49.47 | General |
| Category: Devices | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| DUPIXENT CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $2,940 | 4 |
| OBSERVATIONAL STUDY OF CONJUNCTIVITIS IN THE SETTING OF DUPIXENT TREATMENT FOR ATOPIC DERMATITIS | Regeneron Pharmaceuticals, Inc. | $2,873 | 4 |
| BAWH_KSI | KOWA COMPANY, LTD. | $1,140 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,089 | 1,341 | $637,215 | $139,364 |
| 2022 | 18 | 1,224 | 1,489 | $544,436 | $141,744 |
| 2021 | 18 | 1,210 | 1,447 | $498,310 | $139,546 |
| 2020 | 19 | 803 | 945 | $317,943 | $85,451 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 255 | 320 | $91,113 | $31,241 | 34.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 50 | 69 | $148,452 | $30,626 | 20.6% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 26 | 31 | $89,342 | $18,822 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 183 | $36,631 | $12,733 | 34.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 29 | 34 | $44,400 | $9,402 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $28,642 | $8,026 | 28.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 32 | 36 | $30,866 | $4,870 | 15.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 85 | 108 | $30,634 | $3,976 | 13.0% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 87 | 171 | $17,100 | $3,767 | 22.0% |
| 66999 | Other procedure on front of eye | Facility | 2023 | 13 | 14 | $52,200 | $3,536 | 6.8% |
| 92025 | Ct scan of cornea | Office | 2023 | 100 | 109 | $21,800 | $2,934 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 30 | $8,062 | $1,995 | 24.7% |
| 67999 | Other procedure on eyelid | Office | 2023 | 11 | 12 | $3,600 | $1,646 | 45.7% |
| 68115 | Removal of growth of eyelid lining, more than 1.0 cm | Facility | 2023 | 11 | 14 | $6,342 | $1,638 | 25.8% |
| 92134 | Imaging of retina | Office | 2023 | 31 | 32 | $5,424 | $1,092 | 20.1% |
| 92285 | Photography of content of eyes | Office | 2023 | 38 | 41 | $6,238 | $813.64 | 13.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 15 | $3,005 | $717.49 | 23.9% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 12 | 19 | $6,612 | $643.41 | 9.7% |
| 92132 | Imaging of front third of eye | Office | 2023 | 23 | 25 | $3,292 | $605.68 | 18.4% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 16 | 16 | $3,460 | $278.98 | 8.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 282 | 352 | $80,960 | $35,074 | 43.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 43 | 60 | $112,758 | $27,458 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 160 | $28,651 | $10,978 | 38.3% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 17 | 18 | $49,966 | $10,635 | 21.3% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 57 | 70 | $58,696 | $10,547 | 18.0% |
About Dr. Esen Akpek, M.D
Dr. Esen Akpek, M.D is a Ophthalmology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851356943.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Esen Akpek, M.D has received a total of $627,113 in payments from pharmaceutical and medical device companies, with $188,970 received in 2024. These payments were reported across 239 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($561,919).
As a Medicare-enrolled provider, Akpek has provided services to 4,326 Medicare beneficiaries, totaling 5,222 services with total Medicare billing of $506,105. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Baltimore, MD
- Active Since 04/20/2006
- Last Updated 04/06/2015
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1851356943
Products in Payments
- Product in Development (Device) $470,876
- DUPIXENT (Biological) $39,310
- XIIDRA (Drug) $20,742
- DUPIXENT DUPILUMAB INJECTION (Biological) $16,208
- NO PRODUCT DISCUSSED (Drug) $6,448
- ACTHAR (Biological) $3,700
- TEPEZZA (Biological) $2,500
- Oxervate (Drug) $2,400
- CEQUA (cyclosporine ophthalmic solution) 0.09% (Drug) $1,569
- VEVYE (Drug) $1,400
- OXERVATE (Drug) $600.00
- BOTOX (Biological) $126.40
- Clareon (Device) $51.93
- DEXTENZA (Drug) $50.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Baltimore
Dr. Alfred Sommer, M.d, M.D
Ophthalmology — Payments: $3.7M
Peter Mcdonnell
Ophthalmology — Payments: $2.2M
Neil Bressler, M.d, M.D
Ophthalmology — Payments: $524,415
Peter Campochiaro, M.d, M.D
Ophthalmology — Payments: $257,471
Jennifer Thorne, M.d, M.D
Ophthalmology — Payments: $201,745
Dr. Earl Craven, Md, MD
Ophthalmology — Payments: $187,007